| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000022639 |
| Receipt No. | R000026099 |
| Official scientific title of the study | Neural mechanism of concurrent speech |
| Date of disclosure of the study information | 2016/06/09 |
| Last modified on | 2016/06/09 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Neural mechanism of concurrent speech | |
| Title of the study (Brief title) | Neural mechanism of concurrent speech | |
| Region |
|
|
| Condition | |||
| Condition | healthy | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Revealing neural mechanism of concurrent speech using fMRI |
| Basic objectives2 | Others |
| Basic objectives -Others | Revealing neural mechanism of perception of different speech simultaneously |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | hemodynamic response |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Educational,Counseling,Training | |
| Type of intervention |
|
|
| Interventions/Control_1 | Functional magnetic resonance imaging, maximum 60 minutes per day, two days. Using 3 Tesla MRI. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Voluntary participating healthy colleage students. | |||
| Key exclusion criteria | History of neurological disorders, metals inside body, extremely short-sighted, pregnant, auditory problems, left-handed are excluded. | |||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Ryuta Kawashima |
| Organization | Tohoku University |
| Division name | Institute of Development, Aging and Cancer, Applied Brain Science |
| Address | Seiryo-cho 4-1, Aoba-ku Sendai |
| TEL | 022-707-7988 |
| ruta@tohoku.ac.jp | |
| Public contact | |
| Name of contact person | Teruo Hashimoto |
| Organization | Tohoku University |
| Division name | Institute of Development, Aging and Cancer, Division of Developmental Cognitive Neuroscience |
| Address | Seiryo-cho 4-1, Aoba-ku Sendai |
| TEL | 022-707-8457 |
| Homepage URL | |
| teruo.hashimoto.d6@tohoku.ac.jp | |
| Sponsor | |
| Institute | Tohoku University |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Tohoku University |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026099 |